Use of pictograms in OTC labeling needs data support, P&G attorney says.
This article was originally published in The Tan Sheet
Executive Summary
OTC LABEL USE OF PICTOGRAMS NEEDS DATA SUPPORT showing that pictograms will not miscommunicate patient information, Procter & Gamble attorney Robert Anderson maintained at a Jan. 18 workshop on OTC drug labeling and consumer communication sponsored by the Drug Information Association. The OTC "industry is very nervous" about the use of pictograms, Anderson said, since pictograms have been "shown to mean a lot of different things" to different populations.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: